Cargando…
Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course
BACKGROUND: Systemic juvenile idiopathic arthritis (sJIA) is commonly considered an autoinflammatory disease. However, sJIA patients may develop aggressive arthritis without systemic inflammation later in the disease, resembling an autoimmune phenotype similar to other subtypes of JIA. The objective...
Autores principales: | Hügle, Boris, Hinze, Claas, Lainka, Elke, Fischer, Nadine, Haas, Johannes-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127434/ https://www.ncbi.nlm.nih.gov/pubmed/25114627 http://dx.doi.org/10.1186/1546-0096-12-28 |
Ejemplares similares
-
Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis – data from the German AID-registry
por: Lainka, Elke, et al.
Publicado: (2021) -
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
por: Scheuern, Andrea, et al.
Publicado: (2016) -
α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis
por: Zeller, Ludwig, et al.
Publicado: (2022) -
Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis
por: Hügle, Boris, et al.
Publicado: (2017) -
Treatment preferences in juvenile idiopathic arthritis – a comparative analysis in two health care systems
por: Hugle, Boris, et al.
Publicado: (2013)